Drug Delivery

To ensure that biotechnologically produced drugs are not recognized as foreign by the immune system and eliminated prematurely from the body, biotechnology uses different methods for modifying them so that effective drug delivery is possible.

celares gmbh is specialized in modifying biopharmaceuticals with polyethylene glycols (PEG), through which active ingredients have a longer effect in the body and are more soluble. Whereas in this technology the ingredients are chemically coupled with PEG, Alrise Biosystems GmbH encapsulates biotechnological ingredients with a microparticle envelope. This envelope prevents the drugs from decomposing in the liver, but instead allows them to be released in a controlled manner into the body.
The above technologies not only reduce side effects; the drugs also need to be taken less frequently.

Drug delivery is not only interesting for newly developed substances: Biopharmaceuticals already on the market can gain new patent protection with the aid of a new form of administration.

News innovation

Eckert & Ziegler Starts Development Cooperation for Prostate Cancer Diagnosis

The Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, S-DAX) and the Israeli Isotopia Molecular Imaging Ltd. (Isotopia) will in future work more closely together in the...

more ...

Eckert & Ziegler will be admitted to SDax

Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry will be admitted to SDax as of 24

more ...

BIO International Convention in Philadelphia

Events Campus

25.02.2020, 18:00
Campus Cinema: "The Revenant - Der Rückkehrer"

27.02.2020, 11:00
Begleitung: MINT-EC-Digitalforum 2020

03.03.2020, 16:00
Insektensterben – Ursachen und Folgen

Vorlesungsreihe: Neue Wege in der Biomedizin - Aktuelle Forschungsthemen vom Campus Berlin-Buch

more ...

Sponsoren der Website: